The authors of Yet another paper reported the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].These final results differ substantially from those described by Maalej et al. [24], who shown a reduction in central macular thick